Kristin Heerlein, MD, PhD, MBA

Global Indication Lead, Medical Affairs and Evidence Generation
argenx BV, Belgium

Poster(s):

• (241) Comparative effectiveness and economic evaluation of immunomodulatory therapies in generalized myasthenia gravis
  Wednesday, October 29, 2025